Dravet is a problematic disease in the field of the nervous system, with clinical performance being complex and often involving multi-system congestion. Early identification and normalisation of the disease are essential for improving the prognosis. Diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing and pathological activation.
The platform can assist in connecting a team of authoritative experts at home and abroad to provide accurate diagnostics and treatment programs. Treatment and management of Dravet requires the development of a multi-dimensional treatment plan, which usually includes drug therapy, rehabilitation interventions, and regular follow-up. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many neurological diseases that have been difficult to treat have been significantly improved.
Treatment requires close monitoring of efficacy and adverse reactions and timely adjustment to changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of Dravet. The platform serves a team of nationally and internationally authoritative experts in the field of neural systems aligned with the International Medical Service System of China, providing the following services to patients: 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.